Your browser doesn't support javascript.
loading
Stixis scandens leaf extract-loading ZnO nanoparticles for porcine epidemic diarrhea virus (PEDV) treatment.
Le, Thi Thu Huong; Than, Thi Tam; Lai, Thi Ngoc Ha; Le, Van Phan.
  • Le TTH; Faculty of Natural Resources and Environment, Vietnam National University of Agriculture Trau Quy, Gia Lam Hanoi Vietnam lethithuhuong@vnua.edu.vn.
  • Than TT; Institute of Veterinary Science and Technology Trau Quy, Gia Lam Hanoi Vietnam.
  • Lai TNH; College of Veterinary Medicine, Vietnam National University of Agriculture Hanoi Vietnam letranphan@vnua.edu.vn.
  • Le VP; College of Veterinary Medicine, Vietnam National University of Agriculture Hanoi Vietnam letranphan@vnua.edu.vn.
RSC Adv ; 14(13): 8779-8789, 2024 Mar 14.
Article en En | MEDLINE | ID: mdl-38495987
ABSTRACT
Porcine epidemic diarrhea (PED) is one of the diseases that causes great losses for livestock farmers. Because vaccines against the disease are not very effective, there is a great demand for biological products with effective resistance to PED virus (PEDV). One of the most important trends today is the use of active ingredients from nature in animal husbandry. This study aimed to create an effective agent against PEDV from the extract of Stixis scandens, which has been shown to inhibit PEDV. The aqueous (denoted as TCN) and ethanolic extracts (denoted as TCC) of Stixis scandens leaves were first prepared and then qualitatively analyzed for their chemical compositions. The TCN was used to synthesize ZnO nanoparticles (NPs) at various sizes from 20 to 120 nm. Subsequently, TCC was loaded on ZnO NPs to form ZnO-extract nanoformulations with an extract loading content of 5.8-7.6%. Total polyphenols (TP) and total alkaloids (TA) in TCC were 38.51 ± 0.25 µg GAE per mg and 22.37 ± 0.41 µg AtrE per mg, respectively. TP was less loaded but more released from the nanoformulations than TA. The A1T nanoformulation, containing only 7.6% extract, had a minimum PEDV inhibitory concentration of 3.9 µg mL-1, which was comparable to that of TCC. The experiments confirmed that the nanoformulations are promising for PEDV inhibition applications.